BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES

BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES was reported 27 times

These drug classes are most commonly taken by patients reporting BENIGN ENLARGEMENT OF THE SUBARACHNOID SPACES:

# Drug Count
0 Atypical Antipsychotic [EPC] 8
1 Benzodiazepine [EPC] 3
2 Corticosteroid [EPC] 3
3 Aldosterone Antagonist [EPC] 2
4 Loop Diuretic [EPC] 2
5 Nonsteroidal Anti-inflammatory Drug [EPC] 2
6 Platelet Aggregation Inhibitor [EPC] 2
7 Vitamin B12 [EPC] 2
8 Vitamin C [EPC] 2
9 Vitamin D [EPC] 2
10 Androgen [EPC] 1
11 Angiotensin 2 Receptor Blocker [EPC] 1
12 Angiotensin Converting Enzyme Inhibitor [EPC] 1
13 Anti-IgE [EPC] 1
14 Arteriolar Vasodilator [EPC] 1
15 CD20-directed Cytolytic Antibody [EPC] 1
16 Cytochrome P450 3A Inhibitor [EPC] 1
17 HMG-CoA Reductase Inhibitor [EPC] 1
18 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
19 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
20 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
21 Integrin Receptor Antagonist [EPC] 1
22 Interferon beta [EPC] 1
23 Interleukin-17A Antagonist [EPC] 1
24 Interleukin-23 Antagonist [EPC] 1
25 Janus Kinase Inhibitor [EPC] 1
26 Kinase Inhibitor [EPC] 1
27 Nicotinic Acid [EPC] 1
28 Nitrofuran Antibacterial [EPC] 1
29 Non-Standardized Chemical Allergen [EPC] 1
30 Non-Standardized Food Allergenic Extract [EPC] 1
31 Non-Standardized Plant Allergenic Extract [EPC] 1
32 Protease Inhibitor [EPC] 1
33 Provitamin D2 Compound [EPC] 1
34 Recombinant Human Growth Hormone [EPC] 1
35 Sphingosine 1-phosphate Receptor Modulator [EPC] 1
36 Stimulant Laxative [EPC] 1
37 Thalidomide Analog [EPC] 1
38 Thiazide Diuretic [EPC] 1
39 Vitamin K [EPC] 1
40 Warfarin Reversal Agent [EPC] 1